These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 18587135

  • 21. Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load.
    Arnó A, Ruiz L, Juan M, Jou A, Balagué M, Zayat MK, Marfil S, Martínez-Picado J, Martínez MA, Romeu J, Pujol-Borrell R, Lane C, Clotet B.
    J Infect Dis; 1999 Jul; 180(1):56-60. PubMed ID: 10353861
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment.
    David D, Naït-Ighil L, Dupont B, Maral J, Gachot B, Thèze J.
    J Infect Dis; 2001 Mar 01; 183(5):730-5. PubMed ID: 11181149
    [Abstract] [Full Text] [Related]

  • 24. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L, Ryder LP, Albrecht-Beste E, Jensen FK, Nielsen SD.
    Scand J Immunol; 2009 Dec 01; 70(6):608-13. PubMed ID: 19906203
    [Abstract] [Full Text] [Related]

  • 25. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy.
    Orsilles MA, Pieri E, Cooke P, Caula C.
    APMIS; 2006 Jan 01; 114(1):55-60. PubMed ID: 16499662
    [Abstract] [Full Text] [Related]

  • 26. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S, Vallejo A, Díaz L, Soriano-Sarabia N, Ferrando-Martínez S, Resino S, Muñoz-Fernández MA, Leal M.
    J Antimicrob Chemother; 2009 Sep 01; 64(3):579-88. PubMed ID: 19608579
    [Abstract] [Full Text] [Related]

  • 27. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
    Tedaldi EM, Chen L, Markowitz N, Kelly L, Abrams D, CPCRA Hepatitis Working Group.
    J Viral Hepat; 2005 Jul 01; 12(4):414-20. PubMed ID: 15985013
    [Abstract] [Full Text] [Related]

  • 28. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.
    Clin Immunol; 2006 Nov 01; 121(2):191-7. PubMed ID: 16987710
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM, Levy Y, Fournier I, Hamonic S, Bentata M, Beck-Wirth G, Gougeon ML, Venet A, Madelaine I, Sereni D, Jeanblanc F, Boulet T, Simon F, Aboulker JP, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 119 Interstart Study Team.
    J Infect Dis; 2009 Jul 15; 200(2):206-15. PubMed ID: 19508157
    [Abstract] [Full Text] [Related]

  • 32. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
    Voirin N, Routy JP, Smith D, Baratin D, Trépo C, Cotte L, Touraine JL, Livrozet JM, Cooper DA, Ritter J, André P, Vanhems P.
    HIV Med; 2008 Jul 15; 9(6):440-4. PubMed ID: 18705761
    [Abstract] [Full Text] [Related]

  • 33. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR.
    J Infect Dis; 2010 Oct 15; 202(8):1254-64. PubMed ID: 20812848
    [Abstract] [Full Text] [Related]

  • 34. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.
    AIDS; 2008 Aug 20; 22(13):1583-8. PubMed ID: 18670217
    [Abstract] [Full Text] [Related]

  • 35. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 20; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 36. Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion.
    Miller KD, Spooner K, Herpin BR, Rock-Kress D, Metcalf JA, Davey RT, Falloon J, Kovacs JA, Polis MA, Walker RE, Masur H, Lane HC.
    Clin Immunol; 2001 Apr 20; 99(1):30-42. PubMed ID: 11286539
    [Abstract] [Full Text] [Related]

  • 37. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
    Manfredi R, Calza L, Chiodo F.
    J Biol Regul Homeost Agents; 2006 Apr 20; 20(1-2):1-9. PubMed ID: 18088548
    [Abstract] [Full Text] [Related]

  • 38. [The role of therapeutic use of interleukin-2 in HIV infection].
    Knysz B, Gasiorowski J, Inglot M, Rymer W, Szymczak A, Gładysz A.
    Przegl Epidemiol; 2002 Apr 20; 56(4):587-93. PubMed ID: 12666584
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM, Kosinski AS, Bartlett JA.
    Antivir Ther; 2007 Apr 20; 12(7):1041-8. PubMed ID: 18018762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.